102940 — KOLON LIFE SCIENCE Balance Sheet
0.000.00%
- KR₩391bn
- KR₩505bn
- KR₩161bn
- 12
- 27
- 81
- 32
Annual balance sheet for KOLON LIFE SCIENCE, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 15,031 | 27,910 | 6,371 | 7,480 | 12,417 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 22,647 | 20,304 | 30,029 | 25,634 | 37,808 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 100,563 | 98,021 | 110,184 | 105,045 | 102,055 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 141,893 | 131,481 | 125,960 | 123,138 | 115,076 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 248,338 | 234,658 | 314,118 | 309,436 | 419,563 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 145,152 | 95,469 | 109,578 | 128,341 | 206,255 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 190,381 | 135,248 | 146,395 | 171,764 | 270,225 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 57,957 | 99,410 | 167,723 | 137,672 | 149,338 |
| Total Liabilities & Shareholders' Equity | 248,338 | 234,658 | 314,118 | 309,436 | 419,563 |
| Total Common Shares Outstanding |